2.26
price up icon0.44%   0.010
after-market Handel nachbörslich: 2.33 0.07 +3.10%
loading
Schlusskurs vom Vortag:
$2.25
Offen:
$2.26
24-Stunden-Volumen:
300.43K
Relative Volume:
0.35
Marktkapitalisierung:
$240.50M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-6.6471
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
+7.62%
1M Leistung:
+2.73%
6M Leistung:
-51.71%
1J Leistung:
-52.82%
1-Tages-Spanne:
Value
$2.26
$2.305
1-Wochen-Bereich:
Value
$2.12
$2.37
52-Wochen-Spanne:
Value
$2.00
$5.20

Maxcyte Inc Stock (MXCT) Company Profile

Name
Firmenname
Maxcyte Inc
Name
Telefon
301-517-5556
Name
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
MXCT's Discussions on Twitter

Vergleichen Sie MXCT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
MXCT
Maxcyte Inc
2.26 239.22M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
126.35 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.84 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.69 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.97 119.08B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.49 46.93B 5.69B 4.15B 623.10M 6.95

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-22 Eingeleitet Stephens Overweight
2023-11-29 Eingeleitet Craig Hallum Buy
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-24 Eingeleitet BTIG Research Buy
2021-08-24 Eingeleitet Cowen Outperform
2021-08-24 Eingeleitet Stephens Overweight
2021-08-24 Eingeleitet Stifel Buy
2021-08-24 Eingeleitet Wedbush Outperform
2021-08-24 Eingeleitet William Blair Outperform
Alle ansehen

Maxcyte Inc Aktie (MXCT) Neueste Nachrichten

pulisher
08:06 AM

Leading vs lagging indicators on MaxCyte Inc. performanceFree Access to Real-Time Trade Insights - Newser

08:06 AM
pulisher
04:12 AM

New York State Common Retirement Fund Raises Stock Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

04:12 AM
pulisher
Jul 27, 2025

What is the dividend policy of MaxCyte Inc. stockGet daily updates on promising stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is MaxCyte Inc. a growth stock or a value stockAchieve breakthrough investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying MaxCyte Inc. stockAchieve breakthrough investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does MaxCyte Inc. compare to its industry peersBuild a winning portfolio with smart picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why MaxCyte Inc. stock attracts strong analyst attentionFree Stock Market Beginners Guide - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

MaxCyte Inc. Company’s Quarterly Earnings Growth: What the Numbers SayBig Profit Small Risk Alerts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes MaxCyte Inc. stock price move sharplyHigh Return Conservative Stocks - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

How MaxCyte Inc. stock performs during market volatilitySmart High Yield Swing Trades - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives MaxCyte Inc. stock priceHigh-yield investments - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

MaxCyte (NASDAQ:MXCT) Research Coverage Started at Stephens - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

What makes MaxCyte Inc. stock attractive to long term investorsRapid growth trajectories - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is MaxCyte Inc. a good long term investmentHigh-return market picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about MaxCyte Inc. stockRapid portfolio appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

MaxCyte Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Published on: 2025-07-23 21:52:41 - Autocar Professional

Jul 23, 2025
pulisher
Jul 15, 2025

IWN ETF Implied Analyst Target Price: $198.15 - AInvest

Jul 15, 2025

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Maxcyte Inc-Aktie (MXCT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Soleymannezhad Ali
Chief Commercial Officer
Mar 18 '25
Sale
3.18
1,211
3,850
59,439
Sandoval David I.
GENERAL COUNSEL
Mar 18 '25
Sale
3.18
353
1,122
64,219
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
Mar 18 '25
Sale
3.18
6,939
22,061
111,811
Johnston John Joseph
Director
Jan 27 '25
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Jan 27 '25
Sale
4.64
3,000
13,935
141,950
Sandoval David I.
GENERAL COUNSEL
Jan 13 '25
Sale
4.54
4,466
20,272
41,447
Johnston John Joseph
Director
Dec 26 '24
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Dec 26 '24
Sale
4.01
3,000
12,021
141,950
$292.27
price up icon 0.71%
medical_devices STE
$226.53
price down icon 1.71%
medical_devices PHG
$25.66
price down icon 1.91%
$89.53
price up icon 0.61%
$77.74
price up icon 0.17%
medical_devices EW
$78.49
price down icon 1.89%
Kapitalisierung:     |  Volumen (24h):